Nutritional support teams increase percutaneous endoscopic gastrostomy uptake in motor neuron disease

Table 1 Summary of patient demographic and disease characteristics characteristics of subjects (mean ± SD) or n (%)

Males	49 (57)
Type of MND
Bulbar as predominant symptom	38 (44)
Limb as predominant symptom	48 (56)
Age at symptom onset (yr)	65.0 ± 13.7
Age at diagnosis (yr)	66.4 ± 13.0
Survival after PEG placement (mo)	11.3 ± 10.1
Living arrangements
Alone	13 (15)
With spouse	50 (58)
With other family member	10 (12)
Care facility	7 (8)
Not recorded	6 (7)
Complications during illness
Dysphagia	66 (77)
Respiratory insufficiency	47 (55)
Dementia	5 (6)
Symptom onset to PEG placement (mo)	20.3 ± 8.0
Diagnosis to PEG placement (mo)	10.8 ± 8.3

MND: Motor neuron disease; PEG: Percutaneous endoscopic gastrostomy.